Literature DB >> 9121972

Determinants of nonthoracotomy biphasic defibrillation.

R P Horton1, R C Canby, C A Román, M L Hull, S A Kaye, M E Jessen, R L Page.   

Abstract

The clinical variables affecting DFT for ICD systems are not completely determined, especially with regard to biphasic shocking devices. To distinguish which factors correlate with DFT, we examined data from patients who were enrolled in the Ventak P2/Endotak protocol. A total of 284 patients were enrolled in the study. Two patients had a DFT > 25 J and did not receive the device; 154 did not undergo stepdown to failure DFT testing. The remaining 128 patients had formal DFT testing and were suitable for analysis. Variables available for analysis included age, body surface area (BSA), LVEF, gender, lead configuration, primary arrhythmia, primary cardiac disease, and use of cardioactive medication. Data were evaluated using regression analysis, fitting DFT (range, 1-25 J, mean 11 +/- 5 J) as a function of each variable. As a univariate predictor. BSA was found to be significant in predicting DFT, but accounted for only 9% of the total variation on the DFT (P < 0.01, r = 0.3). This study suggests that DFT using a biphasic shocking waveform is modestly in fluenced by the BSA of the patient. Other specific factors, including LVEF, do not predict DFT.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9121972     DOI: 10.1111/j.1540-8159.1997.tb04812.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  4 in total

1.  Effect of general anesthesia on the defibrillation energy requirement in patients undergoing defibrillator implantation.

Authors:  B P Knight; F Pelosi; M Flemming; F Morady; S A Strickberger
Journal:  J Interv Card Electrophysiol       Date:  1999-12       Impact factor: 1.900

2.  Echocardiographic parameters to predict inadequate defibrillation safety margin in patients receiving implantable cardioverter defibrillators for primary prevention.

Authors:  Sachin Kumar Amruthlal Jain; Hamid Ghanbari; Rayan Hourani; Timothy R Larsen; Marcos Daccarett; Christian Machado
Journal:  J Interv Card Electrophysiol       Date:  2013-01-20       Impact factor: 1.900

3.  Antiarrhythmic Drug Therapy to Avoid Implantable Cardioverter Defibrillator Shocks.

Authors:  Jaber Abboud; Joachim R Ehrlich
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

4.  Does defibrillation threshold increase as left ventricular ejection fraction decreases?

Authors:  Jesus E Val-Mejias; Ashish Oza
Journal:  Europace       Date:  2010-01-03       Impact factor: 5.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.